P-044 External Control Analysis for KarMMa-3: Idecabtagene Vicleucel (Ide-Cel) Vs Real-World Standard of Care (RW SoC; COTA) for Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)
Clinical Lymphoma Myeloma and Leukemia（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined